Jee H Choe

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Drug Administration

Acute Myeloid Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jee H Choe, Tianzhou Yu, Jeremy S Abramson, Mohamed Abou-El-Enein
Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma. Blood advances 8 (2) (2024)
Jee H Choe, Tianzhou Yu, Jeremy S Abramson, Mohamed Abou-El-Enein
Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma. Blood advances 8 (2) (2024)
Jee H Choe, Tianzhou Yu, Jeremy S Abramson, Mohamed Abou-El-Enein
Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma. Blood advances 8 (2) (2024)
Jee H Choe, Tianzhou Yu, Jeremy S Abramson, Mohamed Abou-El-Enein
Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma. Blood advances 8 (2) (2024)
Jee H Choe, Tianzhou Yu, Jeremy S Abramson, Mohamed Abou-El-Enein
Cost-Effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma. Blood advances (2023)